Acquisition leverage TECHLAB is now a brand under SSI Diagnostica Group, a global IVD leader with broad reach and manufacturing capacity. This presents an opportunity to cross-sell SSI Diagnostica’s infectious disease diagnostics solutions to TechLab customers and leverage the combined sales network and credibility of the unified group.

Global reach SSI Diagnostica operates across Denmark, the United States, and China with offices and 11 sites, delivering diagnostics to over 130 countries. Sales teams can position TechLab products alongside SSI’s extensive international footprint to win multi-country contracts and enter new markets.

Scale and credibility As part of a group with over 60 million tests manufactured annually and more than 200 years of combined expertise, TechLab benefits from enhanced brand credibility and potential access to larger procurement opportunities, government tenders, and hospital networks.

Recent leadership A transition in finance leadership and ongoing integration activities suggest potential procurement and contract renewal cycles. Engaging with SSI Diagnostica’s corporate programs could uncover opportunities in cost-optimized purchasing, channel partnerships, or renewal of existing TechLab arrangements.

Market positioning TechLab’s focus on rapid infectious disease tests for gastrointestinal and enteric diseases aligns with SSI Diagnostica’s four disease areas. There is a sales opening to upsell complementary assays, confirmatory tests, and broader microbiology panels to existing customers and new buyers seeking end-to-end solutions.